Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001962870 | SCV002211115 | uncertain significance | Alzheimer disease | 2024-08-14 | criteria provided, single submitter | clinical testing | This variant, c.722_724del, results in the deletion of 1 amino acid(s) of the APP protein (p.Glu241del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs755788810, gnomAD 0.01%). This variant has been observed in individual(s) with Parkinson's disease and dementia (PMID: 25604855, 35861376). ClinVar contains an entry for this variant (Variation ID: 1437591). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Prevention |
RCV003418221 | SCV004116903 | uncertain significance | APP-related disorder | 2024-08-08 | no assertion criteria provided | clinical testing | The APP c.722_724delAAG variant is predicted to result in an in-frame deletion (p.Glu241del). This variant has been reported in patients with Parkinson disease (Chen et al. 2022. PubMed ID: 35861376; Schulte et al. 2015. PubMed ID: 25604855). This variant is reported in 0.012% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |